Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis

Am J Hematol. 2015 Nov;90(11):E212-3. doi: 10.1002/ajh.24176. Epub 2015 Oct 6.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amyloidosis / blood
  • Amyloidosis / diagnosis*
  • Amyloidosis / drug therapy*
  • Amyloidosis / pathology
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers / blood
  • Bortezomib / therapeutic use*
  • Creatinine / blood
  • Cyclophosphamide / therapeutic use
  • Dexamethasone / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Natriuretic Peptide, Brain / blood
  • Peptide Fragments / blood
  • Prognosis
  • Severity of Illness Index
  • Troponin T / blood

Substances

  • Antineoplastic Agents
  • Biomarkers
  • Peptide Fragments
  • Troponin T
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Bortezomib
  • Dexamethasone
  • Cyclophosphamide
  • Creatinine